Literature DB >> 26351351

Management of Squamous Cancer Metastatic to Cervical Nodes With an Unknown Primary Site.

Thomas J Galloway1, John A Ridge2.   

Abstract

Squamous cell carcinoma of an unknown primary (SCCUP) of the head and neck is a rare disease. As a diagnosis of exclusion, the manner in which it is assigned merits consideration. Despite the development and refinement of several techniques designed to locate an occult tumor, including cross-sectional anatomic imaging, functional imaging, and transoral surgical techniques, delineating SCCUP remains an active clinical problem. Its relative rarity has prevented prospective study of the entity. Hence, investigators must rely on retrospective analyses to understand the disease and its appropriate treatment. The current understanding of SCCUP differs substantially from when it was initially described decades ago. The most common site of a small primary tumor initially thought to represent SCCUP is the tonsil or base of the tongue, and an increasing percentage are associated with human papilloma virus. Modern treatment of SCCUP by neck dissection alone, neck dissection followed by radiation with or without concurrent chemotherapy, or primary chemoradiation according to initial nodal disease burden produces extraordinarily low recurrence rates. Whether the potential mucosal primary site and/or the contralateral neck should be electively treated is controversial. Efficacy data seem to be similar; therefore, an evaluation of the toxicity of both treatment paradigms is warranted.
© 2015 by American Society of Clinical Oncology.

Entities:  

Mesh:

Year:  2015        PMID: 26351351     DOI: 10.1200/JCO.2015.61.0063

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  25 in total

1.  Predictors of survival and recurrence after primary surgery for cervical metastasis of unknown primary.

Authors:  Won Ki Cho; Jong-Lyel Roh; Kyung-Ja Cho; Seung-Ho Choi; Soon Yuhl Nam; Sang Yoon Kim
Journal:  J Cancer Res Clin Oncol       Date:  2019-12-19       Impact factor: 4.553

Review 2.  Clinical Utility of In Situ Hybridization Assays in Head and Neck Neoplasms.

Authors:  Peter P Luk; Christina I Selinger; Wendy A Cooper; Annabelle Mahar; Carsten E Palme; Sandra A O'Toole; Jonathan R Clark; Ruta Gupta
Journal:  Head Neck Pathol       Date:  2018-11-22

3.  High levels of centrosomal protein 55 expression is associated with poor clinical prognosis in patients with cervical cancer.

Authors:  Jingyi Qi; Gelin Liu; Fang Wang
Journal:  Oncol Lett       Date:  2018-04-10       Impact factor: 2.967

4.  Factors Influencing the Outcome of Head and Neck Cancer of Unknown Primary (HNCUP).

Authors:  Matthias Balk; Robin Rupp; Konstantinos Mantsopoulos; Matti Sievert; Magdalena Gostian; Moritz Allner; Philipp Grundtner; Markus Eckstein; Heinrich Iro; Markus Hecht; Antoniu-Oreste Gostian
Journal:  J Clin Med       Date:  2022-05-10       Impact factor: 4.964

5.  Patterns of care analysis for head & neck cancer of unknown primary site: a survey inside the German society of radiation oncology (DEGRO).

Authors:  Jens Müller von der Grün; Dimitra Bon; Claus Rödel; Panagiotis Balermpas
Journal:  Strahlenther Onkol       Date:  2018-05-14       Impact factor: 3.621

6.  MiR-195 inhibits the proliferation of human cervical cancer cells by directly targeting cyclin D1.

Authors:  Zhen Li; Hua Wang; Zhiqiang Wang; Hongbing Cai
Journal:  Tumour Biol       Date:  2015-12-02

7.  Expression Of Cyclin D1 Protein Isoforms And Its Prognostic Significance In Cervical Cancer.

Authors:  Jiahui Gu; Xinyu Zhang; Zhuo Yang; Ning Wang
Journal:  Cancer Manag Res       Date:  2019-10-24       Impact factor: 3.989

8.  The prognostic role of radiotherapy and radiotherapy target in cervical lymph node metastatic squamous cell carcinoma with unknown primary: a retrospective study.

Authors:  Ruidan Li; Kai Liao; Zhigong Wei; Zheran Liu; Yan He; Jingjing Wang; Ling He; Xiaoli Mu; Lianlian Yang; Yan Huang; Libang He; Xingchen Peng
Journal:  J Cancer Res Clin Oncol       Date:  2021-07-10       Impact factor: 4.553

9.  TORS elective lingual tonsillectomy has less acute morbidity than therapeutic base of tongue TORS.

Authors:  Mihir R Patel; Lauren Ottenstein; Martha Ryan; Annie Farrell; Matthew Studer; H Michael Baddour; Kelly Magliocca; Christopher Griffith; William Stokes; Jeffrey Switchenko; Ashley Aiken; Mark El-Deiry; C Arturo Solares; Conor Steuer; Nabil Saba; Jonathan Beitler
Journal:  Oral Oncol       Date:  2021-04-17       Impact factor: 5.337

10.  Impact of Neck Dissection in Head and Neck Squamous Cell Carcinomas of Unknown Primary.

Authors:  Yazan Abu-Shama; Julia Salleron; Florent Carsuzaa; Xu-Shan Sun; Carole Pflumio; Idriss Troussier; Claire Petit; Matthieu Caubet; Arnaud Beddok; Valentin Calugaru; Stephanie Servagi-Vernat; Joël Castelli; Jessica Miroir; Marco Krengli; Paul Giraud; Edouard Romano; Jonathan Khalifa; Mélanie Doré; Nicolas Blanchard; Alexandre Coutte; Charles Dupin; Shakeel Sumodhee; Yungan Tao; Vincent Roth; Lionel Geoffrois; Bruno Toussaint; Duc Trung Nguyen; Jean-Christophe Faivre; Juliette Thariat
Journal:  Cancers (Basel)       Date:  2021-05-17       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.